In Vivo Molecular Imaging Building on more than two decades of research in Nuclear Medicine we are proficient in conducting in vivo molecular imaging studies with a translational focus. Imaging studies can be combined with our advanced oncology models to investigate the in vivo biodistribution, e.g. radiolabeled antibodies, or imaging biomarkers in drug efficacy studies. We facilitate clinical translation (Phase I/II) of radio-tracers in collaboration with our clinical partners. Capabilities: Available radiotracers: 18 F-FDG, 18 F-FLT, 18 F-FET, 18 F-NaF, 18 F-FES 68 Ga-PSMA, 68 Ga-RGD 64 Cu-DOTATATE 89 Zr labeled antibodies, e.g. 89 Zr-trastuzumab Custom radiolabeling of small molecules, peptides, proteins and antibodies using e.g. 89 Zr. Imaging modalities: PET/CT imaging SPECT/CT imaging MR imaging Optical (bioluminescence) imaging
